{"disease":{"id":"advanced-hormone-receptor-positive-endocrine-refractory-breast-cancer","name":"advanced hormone receptor positive endocrine refractory breast cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03861403","title":"A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Leap Therapeutics, Inc.","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}